3 Reasons to Buy Aurinia Pharmaceuticals Stock Right Now
Aurinia Pharmaceuticals (NASDAQ: AUPH) has emerged as one of the hottest biotechs on the market this year. Its stock has tripled in value so far in 2017. And that's after a significant pullback of close to 40% from Aurinia's all-time high, set in March.
Some investors might be concerned about that big pullback. However, all of the positives for Aurinia that existed earlier this year are still in place. Actually, the biotech is probably a better investment alternative now than it was in March. Here are three reasons to buy Aurinia Pharmaceuticals stock right now.
Image source: Getty Images.
Source: Fool.com
Aurinia Pharmaceuticals Inc. Aktie
5,18 €
1,65 %
Wenige Einschätzungen bei Aurinia Pharmaceuticals Inc. lassen noch kein klares Bild zu.
Dadurch ergibt sich bei einem Kursziel von 8 € ein stark positives Potenzial von 54.5% im Vergleich zum aktuellen Kurs von 5.18 € bei Aurinia Pharmaceuticals Inc..
